December 17, 2020 | Daily JAM, Dividend Income, PFE |
Next step approval for emergency use authorization from the Food & Drug Administration. Today, Thursday, December 17, a FDA advisory committee voted 20 to 0, with one abstention, that the benefits of the Moderna (MRNA) coronavirus vaccine outweigh any risk.
December 8, 2020 | Daily JAM, Morning Briefing |
A 53-page review published as a Food & Drug Administration briefing document today confirms that the vaccine from Pfizer (PFE) and BioNTech (BNTX) meets the agency’s standards for emergency use authorization. On Thursday, a group of advisers to the FDA will meet for a full-day public meeting to discuss the data and make recommendations on whether the vaccine merits authorization for immediate use. A decision, informed but not dictated by that meeting, is expected from the FDA within days of the meeting. The first doses are expected to be shipped immediately after FDA approval with a target of 6.4 million doses distributed in the first week.
December 3, 2020 | Daily JAM, PFE |
Pfizer (PFE) stock tumbled Thursday after the company reportedly slashed its expectations for coronavirus vaccine deliveries in 2020 due to supply-chain issues. “Scaling up the raw material supply chain took longer than expected,” a company spokeswoman told the Wall Street Journal.Â
November 23, 2020 | Daily JAM, Morning Briefing |
Saying on Sunday that the coronavirus surge in Nevada is running at wildfire levels, Governor Steve Sislak announced new restrictions to start on Tuesday and that will run for three weeks. The new rules will require casinos, amusement and theme parks, arcades, bars, and restaurants to reduce their capacity to 25% from the current 50%. What I think is most interesting to investors, though, is the reaction of stocks with Las Vegas exposure to the news.
November 16, 2020 | Daily JAM, Morning Briefing |
Today Moderna (MRNA) announced that its coronavirus vaccine was 94.5% percent effective. Last Mo... To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with...
November 10, 2020 | Daily JAM |
There's really, really good news in Pfizer's announcement that the coronavirus vaccine it has been developing has turned out to be 90% effective. And that's true even if it turns out that some other company's vaccine becomes the preferred preventative for the...
November 9, 2020 | Daily JAM |
The interim data from Pfizer (PFE) indicated no serious safety concerns, but the data covers a relatively short time period and safety issues could emerge as the company follows trial participants for a longer time. Which is why the U.S. Food & Drug Administration...
November 9, 2020 | Daily JAM, Morning Briefing, Short Term |
Pfizer (PFE) announced today that preliminary data show that the coronavirus vaccine tha... To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of...
October 16, 2020 | Daily JAM, Dividend Income, PFE, Stock Alerts |
In a public letter Pfizer (PFE) CEO Albert Bourla wrote that the company hopes to have initial data from its Phase 3 clinical trail of a coronavirus vaccine by the end of October and that it will wait until the third week in November to file an emergency use...
September 22, 2020 | Daily JAM, Short Term |
Pfizer (PFE) and its partner BioNTech (BNTX) plan to take a first look at the efficacy results from their 44,000 personal vaccine trial as soon as September 27. But that first look will be after just 32 coronavirus infections have accumulated in the two companies'...
September 14, 2020 | Daily JAM, Morning Briefing |
As of noon New York time today the Standard & Poor's 500 was up 1.58% and the Dow Jones Industrials had gained 1.37%. The NASDAQ Composite was higher by 2.01% and the Russell 2000 small cap index had picked up 2.11%. The iShares MSCI Emerging Markets ETF (EEM) had...
September 12, 2020 | Daily JAM, Friday Trick or Trend |
Our regular (or occasional or perhaps occasionally regular) Friday series (actually running on Saturday this week) Trick or Trend looks at what might (or might not) be emerging investible trends. Exclusively on JAM. This post won't run anywhere else. Ever. As...
